Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Price to free cash flow ratio
3Y CAGR
-12.9%/yr
Annual compound
Percentile
P89
Within normal range
vs 3Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 120.45 | +116.7% |
| 2024 | 55.59 | -40.4% |
| 2023 | 93.30 | -48.8% |
| 2022 | 182.28 | +3413.2% |
| 2021 | -5.50 | +31.1% |
| 2020 | -7.99 | -115.9% |
| 2019 | -3.70 | +61.5% |
| 2018 | -9.62 | +23.5% |
| 2017 | -12.57 | +56.5% |
| 2016 | -28.90 | - |